FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37138411000001106: Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
190881000001113 Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
190891000001110 Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Has AMP Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Is a Ranitidine 300mg effervescent tablets 30 tablet true Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Has dispensed dose form Conventional release effervescent oral tablet true Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free false Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Ranitidine 300mg effervescent tablets (Mawdsley-Brooks & Company Ltd) 30 tablet 2 x 15 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start